The partnership arrives as opioid treatment programs struggle to reconcile a surge in federal funding—marked by $1.5 billion in 2025 SAMHSA grants—with a shrinking workforce. With nearly one in three nurses expected to exit the profession by 2027, clinics face an urgent need to optimize administrative workflows. The ZING integration allows staff to transmit dose orders from the Kipu operating system straight to the robotic unit, effectively removing the manual labor of pouring, sealing, and labeling.

Beyond efficiency, the automation addresses the critical bottleneck at the dosing window. By reclaiming time previously lost to repetitive preparation, nurses can refocus on direct patient care and documentation. Opio CEO Sam Wilson reported a 358% return on investment regarding staffing efficiencies at sites already utilizing the ZING technology. As the U.S. market for opioid use disorder treatment is projected to reach $9.64 billion by 2034, this integration provides a scalable architecture for clinics to manage higher patient volumes without proportional increases in headcount. Kipu plans to showcase the joint solution at the upcoming USAOTP Annual Conference 2026.